IP Verse

Transgenic Mice Expressing Chimeric Major Histocompatibility Complex (Mhc) Class Ii Molecules - EP2967015

The patent EP2967015 was granted to Regeneron Pharmaceuticals on Aug 9, 2023. The application was originally filed on Mar 11, 2014 under application number EP14718815A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP2967015

REGENERON PHARMACEUTICALS
Application Number
EP14718815A
Filing Date
Mar 11, 2014
Status
Granted And Under Opposition
May 5, 2023
Grant Date
Aug 9, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

WUESTHOFF & WUESTHOFF PATENTANWALTE PARTG MBBMar 5, 2024WICHMANNADMISSIBLE

Patent Citations (13) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS6586251
DESCRIPTIONUS7294754
DESCRIPTIONWO2009114400
EXAMINATIONWO2014130667
INTERNATIONAL-SEARCH-REPORTUS2007209083
INTERNATIONAL-SEARCH-REPORTWO2005004592
INTERNATIONAL-SEARCH-REPORTWO2013063340
OPPOSITIONEP2770822
OPPOSITIONEP3272214
OPPOSITIONEP3590332
OPPOSITIONUS2007209083
OPPOSITIONUS2013111616
OPPOSITIONWO2013063340

Non-Patent Literature (NPL) Citations (6) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
OPPOSITION- Anonymous, "Antigen Recognition byT Lymphocytes", Anonymous, Peter Parham, The Immune System, 3rd ed., Garland Science, Taylor &Francis Group, LLC, (20090101), pages 1 - 24, ISBN 978-0-8153-4146-8, XP093169138
OPPOSITION- John D Reveille, "MHC Class II and non-MHC genes in the pathogenesis of systemic lupus erythematosus ", John D Reveille, Robert G. Lahita, Systemic Lupus Erythematosus Fourth Edition, Academic Press, (20040101), pages 109 - 151, XP093169169
OPPOSITION- Eva Wielders, "Chapter 11 Generation of Double-Knockout Embryonic Stem Cells", Eva Wielders, Ralf Kuhn , Wolfgang Wurst, Gene knockouts protocols Second Edition , Humana Press, (20090101), pages 205 - 218, doi:10.1007/978-1-59745-471-1_11, ISBN 978-1-934115-26-8, XP093169162
OPPOSITION- Ashutosh K. Mangalam, Govindarajan Rajagopalan, Veena Taneja,,Chella S. David, "HLA Class II Transgenic Mice Mimic Human Inflammatory Diseases", Advances in Immunology, Elsevier, (20080101), pages 65 - 147, doi:10.1016/50065-2776(08)00002-3, ISSN 0065-2776, XP093169159
OPPOSITION- A. Woods, Howard Y Chen, Myrna E Trumbauer, Anna Sirotina, S Rich Cummings, Ll, Dennis M Zaller, "Human major histocompatibility complex class II-restricted T cell responses in transgenic mice", Journal of Experimental Medicine, (19940701), vol. 180, no. 1, doi:10.1084/jem.180.1.173, ISSN 00221007, pages 173 - 181, XP055127351
OPPOSITION- K Ito 1, H J Bian, M Molina, J Han, J Magram, E Saar, C Belunis, D R Bolin, R Arceo, R Campbell, F Falcioni, D Vidović, J Hammer, Z A Nagy, "HLA-DR4-IE chimeric class II transgenic, murine class II-deficient mice are susceptible to experimental allergic encephalomyelitis", Journal of Experimental Medicine, US , (19960601), vol. 183, doi:10.1084/jem.183.6.2635, ISSN 0022-1007, pages 2635 - 2644, XP002919277

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents